Form 4: RAPT Therapeutics Director Linda Kozick Acquires Stock Options
SEC Form 4 Filing
Director Linda Kozick acquired stock options in RAPT Therapeutics, Inc. on May 22, 2024.
Summary
- Linda Kozick, a director of RAPT Therapeutics, Inc., acquired stock options on May 22, 2024.
- The transaction involved the acquisition of options to purchase 36,490 shares of common stock at an exercise price of $4.63.
- The options vest in 12 equal monthly installments starting from the grant date of May 22, 2024, and expire on May 21, 2034.
- Following the transaction, Kozick directly owns options for 36,490 shares.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Date of stock option grant and transaction. |
| 05/21/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.